EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Immune Checkpoints in Leukaemia as Gatekeepers of Immuno‐Modulation

Jeyrubini Ramesh, Kang Zi Khor, Maheswaran Solayappan, Thevendran Ramesh iD, Julia Joseph, Yee Yik Mot, Roshan Mascarenhas iD, Norashikin Zakaria, Norfarazieda Hassan iD, Adam Azlan, Emmanuel Jairaj Moses iD

Immunology · 2026

DOI: 10.1111/imm.70163 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunology, 2026. Verfasst von Jeyrubini Ramesh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, Pusat Kanser Tun Abdullah Ahmad Badawi, Universiti Sains Malaysia, Kepala Batas, Pulau Pinang, Malaysia. Hauptthemen laut MEDLINE: Leukemia, Tumor Escape, Immunomodulation, Immune Checkpoint Proteins. Die Arbeit nennt 176 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Higher Education, Malaysia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune evasion remains one of the key hallmarks in cancer survival by which tumours avoid immune system response. Mechanism of immune evasion involved modulation of immune related cytokines, modulation of tumour microenvironment and immune checkpoints. Intrinsic workings of these mechanisms lead to a network of ‘on’ and ‘off’ switches which could modulate immune activity. Interestingly in leukaemia, a complex network is involved as immune masking occurred concomitantly with leukaemogenesis within the same microenvironment, which makes immune evasion a more elusive hallmark for this disease. Dysregulation of these mechanisms not only facilitates disease persistence and progression but also contributes to resistance against conventional therapies. Therefore, understanding the role of leukaemic immune checkpoints is essential for identifying novel therapeutic targets and improving the efficacy of immunomodulatory treatment strategies. Here, we focus on the leukaemic immune checkpoints as these consist of crucial surface molecules, receptors, ligands, and immunosuppressive cells which interact within the tumour environment to enable leukaemia to elude immune response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeukemiaTumor EscapeImmunomodulationImmune Checkpoint ProteinsHumansTumor MicroenvironmentAnimalsImmune Checkpoint InhibitorsImmunotherapy

Stichwörter der Autor:innen

checkpoint inhibitorsimmune checkpointimmune evasionimmunotherapyleukaemiaoncologyprecision medicine

Substanzen

Immune Checkpoint InhibitorsImmune Checkpoint Proteins

Autor:innen und Institutionen

  • Department of Biomedical Science, Pusat Kanser Tun Abdullah Ahmad Badawi, Universiti Sains Malaysia, Kepala Batas, Pulau Pinang, Malaysia.
  • The Royal College of Surgeons in Ireland and University College Dublin Malaysia Campus, George Town, Pulau Pinang, Malaysia.
  • Faculty of Applied Sciences, AIMST University, Bedong, Kedah, Malaysia.
  • Faculty of Medicine & Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Sabah, Malaysia.
  • Newcastle University Medicine Malaysia (NUMed), Iskandar Puteri, Johor, Malaysia.
  • Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.

ORCID-Profile: Thevendran Ramesh, Roshan Mascarenhas, Norfarazieda Hassan, Emmanuel Jairaj Moses

Förderung

  • Ministry of Higher Education, Malaysia

Zitieren

APA

Ramesh, J., Khor, K. Z., Solayappan, M., Ramesh, T., Joseph, J., Mot, Y. Y., Mascarenhas, R., Zakaria, N., Hassan, N., Azlan, A., & Moses, E. J. (2026). Immune Checkpoints in Leukaemia as Gatekeepers of Immuno‐Modulation. Immunology. https://doi.org/10.1111/imm.70163

Vancouver

Ramesh J, Khor KZ, Solayappan M, Ramesh T, Joseph J, Mot YY, et al. Immune Checkpoints in Leukaemia as Gatekeepers of Immuno‐Modulation. Immunology. 2026. doi:10.1111/imm.70163

BibTeX
@article{Ramesh2026,
  author = {Ramesh, Jeyrubini and Khor, Kang Zi and Solayappan, Maheswaran and Ramesh, Thevendran and Joseph, Julia and Mot, Yee Yik and Mascarenhas, Roshan and Zakaria, Norashikin and Hassan, Norfarazieda and Azlan, Adam and Moses, Emmanuel Jairaj},
  title = {Immune Checkpoints in Leukaemia as Gatekeepers of Immuno‐Modulation},
  journal = {Immunology},
  year = {2026},
  doi = {10.1111/imm.70163}
}
Kostenlos starten →